Research finds home-based kit would increase HIV testing

July 31, 2017, Louisiana State University
Credit: Louisiana State University

Research led by William Robinson, PhD, Associate Research Professor of Behavioral & Community Health Sciences at LSU Health New Orleans School of Public Health, has found that 86% of heterosexuals who are at high risk for HIV would use a home-based test kit provided by mail and 99% would seek treatment based on a positive result. This self-administered alternative may lead a group whose high risk is under-recognized to treatment sooner. The paper is published in the Journal of Acquired Immune Deficiency Syndrome and is available online.

"In 2014, 24% of new HIV infections were attributed to activity," notes Dr. Robinson. "Yet many at-risk individuals do not test routinely or have never been tested."

A total of 470 respondents were surveyed as part of the New Orleans arm of the Centers for Disease Control and Prevention National HIV Behavioral Surveillance of Heterosexuals at increased risk for HIV study in 2013. Eligibility requirements were that participants were 18 years of age or older, residents of the New Orleans metropolitan area, able to take the survey in English and reported having sex with a partner of the opposite sex within the past 12 months.

Of all participants included in the analysis, 85.56% reported that they would be willing to take a home-based test if it was mailed to them by a research study or health department and of those, 54.19% reported that they would return the result back to the provider. Most of remaining participants (43%) reported that they would prefer to only tell their doctor. Only 8 participants (1.7%) reportedly would not reveal the result to anyone.

"Our findings demonstrate that home-based testing could be an effective means to reach some heterosexuals who have never been tested," says Robinson.

Limitations of the study were noted, including that the data were self-reported and that participants were recruited through respondent-driven sampling.

The authors conclude that although further research is needed to evaluate the epidemiologic context under which the assumptions of these models hold true as well as the ethical and logistic considerations, it is clear that increased testing is a critical component of controlling the HIV epidemic.

Explore further: Researchers examine social/behavioral interventions to uncover undiagnosed HIV

More information: William T. Robinson et al, Preferences for Home-Based HIV Testing Among Heterosexuals at Increased Risk for HIV/AIDS, JAIDS Journal of Acquired Immune Deficiency Syndromes (2017). DOI: 10.1097/QAI.0000000000001410

Related Stories

Researchers examine social/behavioral interventions to uncover undiagnosed HIV

December 9, 2016
Despite some evidence that HIV incidence rates in the United States are decreasing modestly in recent years, at least 44,000 people are still infected with HIV each year. Of concern, socioeconomically disadvantaged African ...

Risk, benefit or cost: What stops patients from receiving a diagnostic test?

June 12, 2017
Diagnostic tests can help identify disease and disease probability in patients.

New behavioral intervention targets Latino men at high risk of HIV infection

April 20, 2017
Men who have sex with men (MSM) accounted for two thirds of all new HIV infections in the United States, with 26 percent occurring in Latinos, according to 2014 data. If those rates continue, it is estimated that one in four ...

Grindr, the social networking app, can be an effective way to distribute HIV home-testing kits, study finds

July 12, 2016
A study led by researchers from UCLA found that the gay-oriented social networking app Grindr is an effective means through which to distribute HIV self-testing kits among men who have sex with men who have a high risk for ...

Study finds patients diagnosed late are more likely to transmit HIV to others

October 4, 2016
An estimated 1.2 million people live with HIV in the United States, with nearly 13 percent being unaware of their infection. New research by Brandon Brown in the School of Medicine at the University of California, Riverside ...

Central obesity ups mortality across BMI range

April 25, 2017
(HealthDay)—Central obesity is associated with increased risk of mortality even in normal-weight individuals, according to a study published online April 24 in the Annals of Internal Medicine.

Recommended for you

Researchers find latent HIV reservoirs inherently resistant to elimination by CD8+ T-cells

January 22, 2018
The latest "kick-and-kill" research to eliminate the HIV virus uncovered a potential obstacle in finding a cure. A recent study by researchers at the George Washington University (GW) found that latent HIV reservoirs show ...

HIV-1 genetic diversity is higher in vaginal tract than in blood during early infection

January 18, 2018
A first-of-its-kind study has found that the genetic diversity of human immunodeficiency virus type 1 (HIV-1) is higher in the vaginal tract than in the blood stream during early infection. This finding, published in PLOS ...

War in Ukraine has escalated HIV spread in the country: study

January 15, 2018
Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to analysis by scientists.

Researchers offer new model for uncovering true HIV mortality rates in Zambia

January 12, 2018
A new study that seeks to better ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches, and ultimately, more effective HIV treatment strategies.

New drug capsule may allow weekly HIV treatment

January 9, 2018
Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

January 8, 2018
A team of Yale researchers tested a new chemical compound that suppresses HIV, protects immune cells, and remains effective for weeks with a single dose. In animal experiments, the compound proved to be a promising new candidate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.